Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

BENJAMIN DASTRUP

Allopathic & Osteopathic Physicians Ophthalmology

NPI
1073797809
CMS profile
450949
Location
OGDEN, UT

General Payments · PY2018–2024

$816.16

  • Reported across 36 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$370.13

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $370.13 14

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Apellis Pharmaceuticals, Inc. $68.43 3
Bausch & Lomb Americas Inc. $60.37 3
NEW WORLD MEDICAL,INC. $59.06 1
RxSight Inc $56.14 1
Dompe US, Inc. $40.66 2
ABBVIE INC. $33.34 1
Alcon Laboratories Inc $23.39 1
Oyster Point Pharma, Inc. $14.75 1
Amgen Inc. $13.99 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $39.48 2
PY2019 $84.61 5
PY2020 $75.04 4
PY2021 $59.03 2
PY2022 $82.02 5
PY2023 $105.85 4
PY2024 $370.13 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $33.34 01/10/2024 Food and Beverage Undisputed 01/23/2026 1103603284 CMS
Alcon Vision LLC $23.39 01/11/2024 Food and Beverage Undisputed 01/23/2026 1110674237 CMS
Amgen Inc. $13.99 04/15/2024 Food and Beverage Undisputed 01/23/2026 1111558761 CMS
Apellis Pharmaceuticals, Inc. $14.27 03/04/2024 Food and Beverage Undisputed 01/23/2026 1154017605 CMS
Apellis Pharmaceuticals, Inc. $30.10 07/20/2024 Food and Beverage Undisputed 01/23/2026 1154017607 CMS
Apellis Pharmaceuticals, Inc. $24.06 11/14/2024 Food and Beverage Undisputed 01/23/2026 1154017609 CMS
Bausch & Lomb Americas Inc. $20.85 07/24/2024 Food and Beverage Undisputed 01/23/2026 1140309178 CMS
Bausch & Lomb Americas Inc. $22.74 07/24/2024 Food and Beverage Undisputed 01/23/2026 1140309180 CMS
Bausch & Lomb Americas Inc. $16.78 10/18/2024 Food and Beverage Undisputed 01/23/2026 1140309176 CMS
Dompe US, Inc. $19.73 02/22/2024 Food and Beverage Undisputed 01/23/2026 1151398237 CMS
Dompe US, Inc. $20.93 10/28/2024 Food and Beverage Undisputed 01/23/2026 1151398239 CMS
NEW WORLD MEDICAL,INC. $59.06 06/04/2024 Food and Beverage Undisputed 01/23/2026 1137398203 CMS
Oyster Point Pharma, Inc. $14.75 02/28/2024 Food and Beverage Undisputed 01/23/2026 1147427701 CMS
RxSight Inc $56.14 11/07/2024 Food and Beverage Undisputed 01/23/2026 1144215182 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.